APA Citatie

Koehler, B. C., Jassowicz, A., Scherr, A., Lorenz, S., Radhakrishnan, P., Kautz, N., . . . Schulze-Bergkamen, H. (2015). Pan-Bcl-2 inhibitor Obatoclax is a potent late stage autophagy inhibitor in colorectal cancer cells independent of canonical autophagy signaling. BMC Cancer.

Chicago Style citaat

Koehler, Bruno Christian, et al. "Pan-Bcl-2 Inhibitor Obatoclax Is a Potent Late Stage Autophagy Inhibitor in Colorectal Cancer Cells Independent of Canonical Autophagy Signaling." BMC Cancer 2015.

MLA citatie

Koehler, Bruno Christian, et al. "Pan-Bcl-2 Inhibitor Obatoclax Is a Potent Late Stage Autophagy Inhibitor in Colorectal Cancer Cells Independent of Canonical Autophagy Signaling." BMC Cancer 2015.